Tag: life sciences
-
Digital Neuroscience Companies Partner on AR/AI Diagnostics
Two companies creating digital technologies for neurological conditions are collaborating on augmented reality and artificial intelligence in diagnostics.
-
NIH Small Biz Grant Supports Uterine Health Diagnostic
A women’s health diagnostics developer is receiving funds for a non-invasive test analyzing menstrual fluids to detect the uterine disorder endometriosis.
-
Precision Meds Continue Gaining FDA Approvals
Food and Drug Administration approved 17 new medications in 2021 addressing genetic targets, according to data from a precision medicine advocacy group.
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
Infographic – Simulated Clinical Trials Gain Traction
In 2021, 15 simulated or in silico trials, as they’re called, were underway, a rapid jump in this technique from the two trials reported 2018.
-
Precise Stimulation Shown to Reduce Parkinson Symptoms
Light-activated stimulation of a precise set of nerve cells in the brainstem is shown to improve motor abilities in lab mice induced with Parkinson’s disease.
-
Whole Genome Sequencing Shown to Detect Neuro Disorders
An analysis of genetic database records indicates a class of neurological diseases can be detected by sequencing of a person’s entire genome.
-
ALS Therapy Start-Up Gains $5.1M in Seed Funds
A start-up enterprise is developing a treatment for amyotrophic lateral sclerosis or ALS, spun off from university research labs and an ALS advocacy group.
-
Trial Begins for Advanced Covid-19 Disease Anti-Viral
A late-stage clinical trial is underway testing an oral anti-viral drug to treat moderate to severe cases of Covid-19 infections.
-
Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.